<DOC>
	<DOC>NCT00112411</DOC>
	<brief_summary>This study is designed to evaluate the single-dose effectiveness of two bronchodilator inhalers given at two dose levels in pediatric asthma patients.</brief_summary>
	<brief_title>Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics</brief_title>
	<detailed_description />
	<mesh_term>Bronchodilator Agents</mesh_term>
	<criteria>Persistent asthma for a minimum of six months duration that has been stable for at least four weeks Predicted FEV1 6090% Demonstration of 12% airway reversibility Continuous requirement for betablockers, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants, anticholinergics and/or steroids other than those inhaled; Presence of clinicallysignificant nonasthmatic acute or chronic disease</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>December 2005</verification_date>
</DOC>